Measuring elimination of gambiense human African trypanosomiasis: a comparison of deceptively different metrics. [PDF]
Sutherland SA, Madan JJ, Rock KS.
europepmc +1 more source
ML-792 impairs <i>Trypanosoma brucei</i> growth through SUMO pathway disruption: toward E1 as a candidate antitrypanosomal target. [PDF]
Fischman ED +3 more
europepmc +1 more source
The major diagnostic VSG LiTat 1.3 of the human parasite Trypanosoma brucei gambiense is a trimer in solution. [PDF]
Danel N +5 more
europepmc +1 more source
Why we need medical entomologists more than ever. [PDF]
Meredith S.
europepmc +1 more source
Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in Uganda. [PDF]
Huang CI +18 more
europepmc +1 more source
Trypanosomatid parasites, translational research in a One Health, One World environment. [PDF]
Ponte-Sucre A.
europepmc +1 more source
Molecular Epidemiology and Co-Circulation of Foot-and-Mouth Disease Serotypes in Ghana, 2024. [PDF]
Odoom T +13 more
europepmc +1 more source
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage. [PDF]
Hendrickx S +19 more
europepmc +1 more source
Human Leukocyte Antigen-G is enriched in presence of trypanosome in the dermis of individuals exposed to gambiense Human African Trypanosomiasis in Guinea and Côte d'Ivoire. [PDF]
Lagrave A +31 more
europepmc +1 more source
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate. [PDF]
Hendrickx S +19 more
europepmc +1 more source

